TAME study
A clinical research trial called 'Targeting Aging with Metformin' designed to investigate whether the drug metformin can slow aging and prevent age-related diseases
As defined in Longevity: TAME study funded! Metformin Trial for Anti-Aging
Where it comes up · 1
Most important claims · 4 of 4Search all claims for “TAME study” →
- The National Institutes of Aging developed the TAME study with dozens of contributors and hundreds of geriatricians, which is unusual because most studies originate from a principal investigator and team developing an idea, writing a proposal, and submitting a grant application for review, rather than being designed by a large institutional collaboration.Longevity: TAME study funded! Metformin Trial for Anti-Aging
- There is a larger population with type 2 diabetes and insulin resistance than commonly recognized, making metformin a relevant intervention for more than just diagnosed diabetics.Longevity: TAME study funded! Metformin Trial for Anti-Aging
- The TAME study (Targeting Aging with Metformin) was designed and written four years before it received funding, with an announcement in September 2017 on USA Today and NBC Nightly News.Longevity: TAME study funded! Metformin Trial for Anti-Aging
- David, a dietician who speaks on health and prevention primarily to dentists and other groups, alerted the speaker to the TAME study.Longevity: TAME study funded! Metformin Trial for Anti-Aging